Atea Pharmaceuticals

Share on: 

Atea is a clinical stage biopharmaceutical company working to address unmet medical needs with innovative oral antiviral therapies based on purine nucleotide prodrug.

COVID-19: Running a phase 2 trial of its oral purine nucleotide prodrug in people hospitalized with moderate cases of COVID-19.

Boston MA
United States